A New Era in Medicine: FDA Approves CRISPR-based Gene Editing Treatment for Sickle Cell Disease
In a monumental stride forward, the U.S. Food and Drug Administration (FDA) has granted approval for Casgevy, the pioneering CRISPR gene-editing treatment developed by Vertex Pharmaceuticals and CRISPR Therapeutics, to combat sickle cell disease (SCD). This historic decision offers a beacon of hope to millions worldwide grappling with this painful and life-altering genetic disorder. Understanding […]